FB Pixel no scriptKrASIA | Decoding China's tech and business pulse
MENU
KrASIA

Features

Bryan Johnson: The man trying to engineer longevity into the human condition

18 mins read

Pulses

Sino Biopharm to fully acquire LaNova

just now
Jiemian News
Sino Biopharmaceutical plans to acquire the remaining 95.09% of LaNova Medicines for up to USD 951 million, raising its stake to 100%. After accounting for LaNova’s estimated USD 450 million in cash, the net payment will be about USD 500 million. The deal strengthens Sino Biopharm’s pipeline as it targets the launch of 30 new drugs by 2027.
See All

Icon for Editor’s PicksEditor’s Picks

Features

MiniMax finds its “aha moment,” and a way to challenge the AI status quo

Don’t let the AI-generated cat videos distract from MiniMax’s growing edge in AI technology.

7 mins read
  • News

    As rivals pile on, Meituan braces for a brutal fight in delivery and commerce

    7 mins read

Venture RoundupVenture Roundup